RichardRobertKosierowskiMD

PubMed

• 8 citations
  Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)
  Corey J. Langer, C. McAleer, C A Bonjo, Samuel Litwin, Michael Millenson, R. Kosierowski, K. Blankstein, R. Alexander, Robert F. Ozols> ;European Journal of Cancer. 2000 Jan 1
• Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
  Stevenson, J. P., Scher, R. M., Kosierowski, R., Fox, S. C., Simmonds, M., Yao, K. S., Green, F., Broom, C., Fields, S. Z., Krebs, J. B., O'Dwyer, P. J.> ;Eur J Cancer. 1998 Aug
• Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
  Langer, C. J., Millenson, M., O'Dwyer, P., Kosierowski, R., Alexander, R., Litwin, S., McAleer, C. A., Bonjo, C. A., Ozols, R.> ;Semin Oncol. 1996 Dec
• Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.
  Scher, R. M., Kosierowski, R., Lusch, C., Alexander, R., Fox, S., Redei, I., Green, F., Raskay, B., Amfoh, K., Engstrom, P. F., O'Dwyer, P. J.> ;Invest New Drugs. 1996
• Phase II study of topotecan in metastatic hormone-refractory prostate cancer.
  Hudes, G. R., Kosierowski, R., Greenberg, R., Ramsey, H. E., Fox, S. C., Ozols, R. F., McAleer, C. A., Giantonio, B. J.> ;Invest New Drugs. 1995
• Join now to see all